Showing results (181-190 of 2,283) with videos related to

Sort By:
Pageof 229
Plos One|January 28, 2014
Do preschool children learn to read words from environmental prints?Jing Zhao, Pei Zhao, Xuchu Weng, et al.
Frontiers in Oncology|September 7, 2021
Prognostic Function of Programmed Cell Death-Ligand 1 in Esophageal Squamous Cell Carcinoma Patients Without Preoperative Therapy: A Systematic Review and Meta-AnalysisHongxia Cui, Yarong Li, Su Li, et al.
Frontiers in Pharmacology|October 3, 2025
Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysisDanxue Huang, Feilong Sun, Su Li, et al.
Frontiers in Pharmacology|July 25, 2024
Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysisLiyuan Ke, Su Li, Danxue Huang, et al.
Future Oncology (London, England)|June 27, 2023
Rash with different types of BCR-ABL inhibitors in chronic myelogenous leukemia: a systematic review and meta-analysisSu Li, Tingwen Wang, Yu Zhong, et al.
Technology in Cancer Research & Treatment|June 22, 2023
A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients with Colon Neuroendocrine Tumors After Surgery: A Surveillance, Epidemiology, and End Results Population-Based StudyXue Zhang, Kui Zhang, Su Li, et al.
Frontiers in Oncology|September 5, 2022
Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysisYu Zhong, Hong Huo, Shuqi Dai, et al.
Medicine|August 16, 2021
Effectiveness of bisphosphonates on bone mineral density in osteopenic postmenopausal women: A systematic review and network meta-analysis of randomized controlled trialsSu-Li Dong, Yongqiang Jiao, Hai-Liang Yang
BMC Cancer|May 24, 2023
Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trialsDanxue Huang, Liyuan Ke, Hongxia Cui, et al.
Oncology Research|September 23, 2011
Combretastatin A4 phosphate induces programmed cell death in vascular endothelial cellsXueqiang Ding, Zhaoqiang Zhang, Su Li, et al.
Pageof 229